S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
USOTC
Institute of Biomedical Research Corporation New (PK) (MRES)
Institute of Biomedical Research Corporation New (PK) (MRES) News

MRES

Institute of Biomedical ... (PK) (MRES)

Institute of Biomedical Research Corporation New (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:MRES

Date	Time	Source	Headline	Symbol	Company
07/19/2023	8:18AM	InvestorsHub NewsWire	MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
07/14/2023	7:52AM	InvestorsHub NewsWire	MRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal Benefits	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
07/06/2023	8:38AM	InvestorsHub NewsWire	MRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment Access	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
07/05/2023	9:04AM	InvestorsHub NewsWire	MRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior Listing	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/26/2023	7:45AM	InvestorsHub NewsWire	MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/16/2023	7:30AM	InvestorsHub NewsWire	MRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for Phytomedicines	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/14/2023	7:00AM	InvestorsHub NewsWire	MRES: M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for Commercialization	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/07/2023	9:06AM	InvestorsHub NewsWire	MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
04/06/2023	6:25AM	InvestorsHub NewsWire	M2Bio Appoints Ze-ev Krein as Chairman of the M2Bio Scientific Advisory Board	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/16/2014	7:45AM	Marketwired	The Institute of Biomedical Research Corp.(MRES.PK) to Take Over Montenegro's National Testing & Research Institution "Center...	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
04/25/2014	1:45PM	Marketwired	Neuro-Biotech Corp. (MRES.PK) Performs Reverse Split and Name Change to The Institute of Biomedical Research Corp.	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
02/10/2014	7:30AM	Marketwired	Neuro-Biotech Corp. (MRES.PK) Performs Reverse Merger With the Institute of Biomedical Research	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
03/29/2013	11:54AM	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/29/2011	4:01PM	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
03/30/2011	4:24PM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
02/09/2011	12:45PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
11/15/2010	2:25PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
09/16/2010	9:34AM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
08/20/2010	1:23PM	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
08/16/2010	11:32AM	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
08/16/2010	9:45AM	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
08/10/2010	9:05AM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
07/27/2010	1:02PM	Marketwired	Neuro-Biotech Corp. - Update to Shareholders	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
07/27/2010	1:02PM	Marketwired	Neuro-Biotech Corp. - Update to Shareholders	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
07/19/2010	12:50PM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
07/02/2010	3:13PM	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/29/2010	4:10PM	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
06/17/2010	12:01PM	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
03/08/2010	5:08AM	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)
12/07/2009	5:15AM	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:MRES	Institute of Biomedical Research Corporation New (PK)

Showing the most relevant articles for your search:USOTC:MRES

Ish $em Crpbd A

Invesco Markets II

Safira Holding S.A ON

Hsbc Em Sus Etf

Eu Tf 1,125% Ap36 Eur

X Em Asia Esg C

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions